Amano’s new premises at Milton Park will oversee all operations across its EMEA sites. The laboratory, comprising cutting-edge R&D equipment, will enable the company to further expand into strategic focus areas, such as plant-based food and drinks.
In addition, said Washisaka, “our new hub will enable us to have greater collaboration between the UK and U.S. offices in terms of research capabilities. We will be launching a significant recruitment drive for R&D, sales and customer service positions, and anticipate doubling our workforce at the park.”
The move to Milton Park coincides with the company’s 30th anniversary in the UK, while 2023 marks its 40th anniversary in Europe.
Founded in 1899, Amano Enzyme is a major specialty enzyme manufacturer with subsidiaries in the USA, Europe, and Asia. Amano Enzyme USA Co., Ltd. supplies high-quality, microbial enzymes for the Food, Dietary Supplement, Industrial, Diagnostic, and Regenerative Medicine Industries to the Americas. With multi-ton manufacturing capabilities, SQF Level 2 certification, and technical expertise Amano is capable of providing unparalleled service along with guaranteed highest quality products.